Atlas Trials

Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis

Clinical trial NCT02631564 · UNKNOWN

Trial details

NCT number
NCT02631564
Sponsor
Fudan University
Status
UNKNOWN
Study type
OBSERVATIONAL
Colon Cancer Liver Metastasis
Start date
2015-06-01
Primary completion
2017-06-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.